The Role of MicroRNAs in the Progression of Metabolic Dysfunction-associated Steatotic Liver Disease

Key Points

• This research aims to explore how micrornas contribute to the progression of metabolic dysfunction-associated steatotic liver disease.
• Investigated the expression levels of micrornas in liver tissue samples.
• Analyzed the relationship between micrornas and metabolic dysfunction markers.
• Utilized statistical models to assess the impact of micrornas on disease progression.
• Elevated levels of specific micrornas were associated with increased liver inflammation.
• Findings suggested a direct link between micrornas and the severity of metabolic dysfunction.
• Certain micrornas showed potential as biomarkers for early detection of MASLD.